CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 75 enrolled
Drug / intervention
Usual Care then FitBit +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03839082
NCT03839082N/ACompleted

A Randomized Controlled Pilot Trial of a Structured Mobile Technology Based Lifestyle Program vs Usual Care for Patients With Non-alcoholic Fatty Liver Disease

University of Michigan·interventional·Posted Feb 15, 2019·Updated May 3, 2022

In Brief

A clinical study evaluating Usual Care then FitBit and FitBit then Usual Care for Non-Alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis. Completed, enrolled 75 participants across 1 site.

Detailed Summary

This study will look at physical activity and nutrition in patients with non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH). The researchers will see if providing patients with NAFLD/NASH with specific physical activity and nutrition feedback as an addition to their usual clinical care helps them to lose weight and improve liver-related parameters.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedFeb 15, 2019
Enrollment StartMar 20, 2019
Primary CompletionFeb 26, 2021
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 7.4 years ago

Interventions

Usual Care then FitBitother

Usual care is a visit (15-20 mins) every 6-12 months. Usual care includes a Fibroscan (FDA 510(k) device).

FitBit then Usual Careother

Intervention is tailored physical activity and nutritional counseling. Step counts are monitored by a FitBit Zip. A Fibroscan (FDA 510(k) device) is done.